Transcriptomic analysis reveals prognostic molecular signatures of stage I melanoma

BACKGROUND: Previously identified transcriptomic signatures have been based on primary and metastatic melanomas with relatively few AJCC stage I tumors given difficulties in sampling small tumors. The advent of adjuvant therapies has highlighted the need for better prognostic and predictive biomarke...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Cancer Res
Autori principali: Thakur, Rohit, Laye, Jonathan P., Lauss, Martin, Diaz, Joey Mark S., O’Shea, Sally Jane, Poźniak, Joanna, Filia, Anastasia, Harland, Mark, Gascoyne, Joanne, Randerson-Moor, Juliette A., Chan, May, Mell, Tracey, Jönsson, Göran, Bishop, D. Timothy, Newton-Bishop, Julia, Barrett, Jennifer H., Nsengimana, Jérémie
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7617074/
https://ncbi.nlm.nih.gov/pubmed/31515461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-3659
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi